We’re on the cusp of a gene editing revolution, are we ready?
By Editorial,
New Scientist
| 07. 27. 2016
THERE’S a certain breed of techno-optimist who likes to talk about “the singularity” – a time when technology progresses so rapidly that life is transformed beyond recognition. The driving force of this hypothetical event is artificial intelligence, but biotech plays a key role too.
...
But there are dangers ahead – not least the science outpacing public consent. Two teams in China have already tried to engineer human embryos. That seems unnecessarily hasty given the ethical issues it raises.
Those who work on CRISPR have a duty to consider not just the science but also how it will be received. As yet, CRISPR has hardly registered in public debate.
Image via Pixabay
Related Articles
By Jallicia A. Jolly, Sydney Curtis and Nicole Sessions, Ms. Magazine | 10.17.2025
Pronatalism is an old idea with roots in eugenics and nationalism, that is now fashionable among far-right influencers and policymakers. They talk of “moral decay” and see low birth rates as a threat to the future of humanity. In the mainstream media...
By Matthew Ormseth and Summer Lin, Los Angeles Times | 10.02.2025
The father of some 22 children discovered by Arcadia police in May also owns a property in El Monte where authorities found evidence of illegal gambling and drug activity, court records show.
Guojun Xuan, 65, told detectives all but two...
By Katherine Bourzac, Nature | 09.25.2025
A judge in New York rejected a request on 23 September to disqualify the use of cutting-edge DNA sequencing as evidence in a case against an alleged serial killer. The ruling paves the way for a type of DNA analysis...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...